Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.

[1]  G. Angelini,et al.  Postoperative acute kidney injury defined by RIFLE criteria predicts early health outcome and long-term survival in patients undergoing redo coronary artery bypass graft surgery , 2016, The Journal of thoracic and cardiovascular surgery.

[2]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[3]  W. Boden,et al.  CABG for Complex CAD: When Will Evidence-Based Practice Align With Evidence-Based Medicine? , 2016, Journal of the American College of Cardiology.

[4]  A. Garg,et al.  Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. , 2006, JAMA.

[5]  E. Hannan,et al.  Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery. , 2015, Journal of the American College of Cardiology.

[6]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[7]  Sean M. O'Brien,et al.  International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design , 2018, American heart journal.

[8]  V. Fuster,et al.  Coronary artery disease Comparative efficacy of coronary artery bypass surgery vs . percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease , 2016 .

[9]  C. Ballantyne,et al.  Coronary artery bypass graft surgery remains the standard of care for patients with diabetes. , 2013, Seminars in thoracic and cardiovascular surgery.

[10]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[11]  R. Wilson,et al.  Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure , 1992, The Lancet.

[12]  P. Serruys,et al.  Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). , 2005, American heart journal.

[13]  P. Pellikka,et al.  Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. , 2017, Kidney international.

[14]  D. Berman,et al.  Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. , 2014, JACC. Cardiovascular interventions.

[15]  J. Fleg,et al.  Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials. , 2018, Kidney international.

[16]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[17]  D. Gotley,et al.  Short- and long-term outcomes , 2006 .

[18]  Maria Mori Brooks,et al.  A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[19]  M. Elayda,et al.  Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. , 2010, The American journal of cardiology.

[20]  B. Scribner,et al.  Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.

[21]  V. Fuster,et al.  Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease. , 2016, Journal of the American College of Cardiology.

[22]  Connie M. Rhee,et al.  US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  J. Spertus,et al.  Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial). , 2013, The American journal of cardiology.

[24]  Sean M. O'Brien,et al.  International Study of Comparative Health Effectiveness with Medical and Invasive Approaches–Chronic Kidney Disease (ISCHEMIA‐CKD): Rationale and design , 2018, American heart journal.

[25]  J. Spertus,et al.  Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. , 2009, The American journal of cardiology.